Dr. Tamer Abdelghany an Associate Professor at Department of Pharmacology and Toxicology, Faculty of Pharmacy, Heliopolis University for Sustainable Development. He got his PhD from Davis Heart and Lung Research Institute (DHLRI), College of Medicine, The Ohio State University, Columbus, Ohio, USA. Afterwards, he spent two years post-doctoral training in Dr. Jay Zweier’s Lab at Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, USA.

     Dr. Tamer Abdelghany’s research focus on the molecular basis, pathogenesis, prevention and treatment of stress-induced diseases such as tobacco smoke and electronic cigarette exposure, drugs and xenobiotics-induced hepatic and kidney injuries, in addition to development of new anti-bacterial and anti-cancer drugs using both cellular and animal models. 


His work has been featured in several well-respected journals including: Nature communication, Journal of biological chemistry (JBC), Journal of medicinal chemistry, Nitric oxide, American journal of Physiology and much more. 

     During his academic life, he taught many subjects, e.g.,  pharmacology I, Pharmacology II, Pharmacology III, Clinical Pharmacy and therapeutics, Toxicology, Biological standardization and biostatistics, Drug information and clinical Pharmacokinetics for both undergraduate and postgraduate students. 



  • Four years scholarship from the Egyptian Ministry of higher education to study my PhD. In the United States.
  • Two year fellowship for post-doctoral training from The Ohio State University, Columbus, Ohio, USA.


Young investigator grant proposal ID 25658, titled:” Crosstalk between survivin-induced chemoresistance and apoptosis inhibition and Retinoic acid signaling in colorectal cancer cells” STDF, Egypt 777 KLE, Role: PI